NeuroProof
NeuroProof is a Contract Research Organization (CRO) specializing in pre-clinical services for neuropharmaceuticals and neurotoxicity testing. They offer innovative Microelectrode Array (MEA)-based phenotypic screening and artificial intelligence-driven analysis to accelerate the discovery of treatments for neurological disorders. Their services include cultivating neuronal cultures on MEA chips, medium-throughput screening, recording network activity, mathematical analysis, and pattern recognition. NeuroProof develops in vitro disease models for conditions such as Alzheimer's, Parkinson's, ALS, epilepsy, and Fragile X syndrome, utilizing primary neuronal cell cultures and human iPSC-derived cell cultures. They also offer molecular biology and imaging assays to support drug discovery.
NeuroProof
NeuroProof is a Contract Research Organization (CRO) specializing in pre-clinical services for neuropharmaceuticals and neurotoxicity testing. They offer innovative Microelectrode Array (MEA)-based phenotypic screening and artificial intelligence-driven analysis to accelerate the discovery of treatments for neurological disorders. Their services include cultivating neuronal cultures on MEA chips, medium-throughput screening, recording network activity, mathematical analysis, and pattern recognition. NeuroProof develops in vitro disease models for conditions such as Alzheimer's, Parkinson's, ALS, epilepsy, and Fragile X syndrome, utilizing primary neuronal cell cultures and human iPSC-derived cell cultures. They also offer molecular biology and imaging assays to support drug discovery.